连续性腹膜透析（CAPD）市场规模、份额和成长分析：按产品类型、透析方法、患者类型、最终用户、分销管道和地区划分－2026-2033年产业预测

2024年全球连续性腹膜透析（CAPD）市值为95亿美元，预计2025年将成长至100.5亿美元，到2033年将成长至157.8亿美元。预测期（2026-2033年）的复合年增长率预计为5.8%。

全球持续性携带式腹膜透析（CAPD）市场主要受慢性肾臟病率上升和居家照护需求成长的推动。 CAPD使患者能够全天独立管理治疗，提高生活方式的柔软性，并最大限度地减少就医次数，这对于不堪重负的医疗系统至关重要。市场正从手动解决方案转向先进的液体配方和导管设计，同时整合教育计画以促进更广泛的应用。成本控制压力，加上远端医疗监测和材料改进等技术创新，透过减少併发症和改善患者预后，推动了CAPD的普及。此外，人工智慧技术透过远端监测和个人化患者支持，正在革新治疗依从性和治疗效果，为更积极主动、以患者为中心的护理铺平道路。

全球持续性腹膜透析（CAPD）市场驱动因素

慢性肾臟病盛行率的不断上升导致需要透析的患者数量显着增加，从而推动了对便利的居家治疗方法（例如持续性腹膜透析 (CAPD)）的需求。随着医疗保健系统向门诊治疗转型，医护人员和患者都在积极寻求能够提升自主性并减少对医疗机构依赖的解决方案。这种转变促使人们增加对训练、耗材和支援服务的投入，以提高 CAPD 的可近性和接受度。因此，随着越来越多的患者寻求便利的居家护理，而医护人员则专注于有效的容量管理和提高护理的连续性，市场持续扩张。

全球持续携带式腹膜透析（CAPD）市场面临的限制因素

全球持续性携带式腹膜透析（CAPD）市场面临严峻挑战，主要原因是居家透析服务和耗材的报销体係不完善且分散。这种不一致的保险覆盖范围为患者和医疗服务提供者都带来了经济上的不确定性，导致他们不愿意选择CAPD。除非有可靠的支付管道得到保障，否则医疗服务提供者可能不愿投入资源进行必要的培训和家庭支持，而供应商则面临着难以预测的市场进入。因此，这种情况阻碍了临床医生推荐CAPD和患者的接受度，限制了对服务网络的投资，并阻碍了在各种医疗环境中广泛应用CAPD所需的基础设施建设。

全球持续性腹膜透析（CAPD）市场趋势

全球持续性腹膜透析（CAPD）市场正经历着向居家护理的显着转变，这主要得益于医疗服务提供者和患者对腹膜居家照护的日益青睐，这种透析方式允许患者在传统医疗机构之外接受治疗。这项转变推动了对病患教育和护理支援计画的投入，以及对简化设备设计以提高易用性的努力。支付机构和医疗系统优先考虑的是护理的连续性、减少对住院治疗的依赖以及提高患者的生活质量，这促使各方加强合作，旨在优化培训和供应物流。製造商则透过提高耗材的便携性和便利性、推广分散式服务模式、增加看护者的参与以及构建以患者为中心的综合护理路径来应对这一趋势，从而将临床结果与以患者为中心的理念相结合。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球连续性腹膜透析（CAPD）市场规模：依产品类型及复合年增长率（2026-2033）划分

• CAPD溶液
  • 标准葡萄糖溶液
  • 艾考糊精溶液
  • 胺基酸溶液
• CAPD 设备和配件
  • 导管
  • 转移装置
  • 连接器
  • 其他配件

全球连续性腹膜透析（CAPD）市场规模：依透析方法及复合年增长率（2026-2033）划分

• 传统 CAPD
• 自动中央动脉灌洗液（APD）

全球连续性腹膜透析（CAPD）市场规模：依病患类型及复合年增长率（2026-2033）划分

• 成年患者
• 儿童患者
• 老年患者

全球连续性腹膜透析（CAPD）市场规模：按最终用户和复合年增长率划分（2026-2033 年）

• 医院
• 透析中心（独立机构）
• 居家医疗环境
• 专科诊所
• 其他的

全球连续性腹膜透析（CAPD）市场规模：依分销管道及复合年增长率（2026-2033）划分

• 在线的
• 离线

全球连续性腹膜透析（CAPD）市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Medtronic plc
• B. Braun Melsungen AG
• CareDX, Inc.
• Terumo Corporation
• 3M Health Care
• Dialysis Clinic, Inc.
• Gambro AB
• Nipro Corporation
• ICU Medical, Inc.
• Sorin Group
• NxStage Medical, Inc.
• Asahi Kasei Medical Co., Ltd.
• DaVita Inc.
• Abbot Laboratories
• Polymedicure Inc.
• Medline Industries, Inc.
• Renal Services Group
• Fresenius Kabi AG

结论与建议

Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market size was valued at USD 9.5 Billion in 2024 and is poised to grow from USD 10.05 Billion in 2025 to USD 15.78 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global market for Continuous Ambulatory Peritoneal Dialysis (CAPD) is significantly influenced by the increasing prevalence of chronic kidney disease and the growing preference for home-based therapies. CAPD enables patients to manage their treatment independently throughout the day, enhancing lifestyle flexibility and minimizing hospital visits, which is crucial for overloaded healthcare systems. The market has transitioned from manual solutions to advanced fluid formulations and catheter designs while integrating educational programs to facilitate broader access. Cost containment pressures coupled with technological innovations, such as telehealth monitoring and improved materials, support CAPD's adoption by reducing complications and enhancing patient outcomes. Furthermore, AI technologies are revolutionizing adherence and outcomes through remote monitoring and personalized patient support, paving the way for more proactive, patient-centered care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Continuous Ambulatory Peritoneal Dialysis (Capd) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market Segments Analysis

Global continuous ambulatory peritoneal dialysis (capd) market is segmented by product type, dialysis modality, patient type, end users, distribution channel and region. Based on product type, the market is segmented into Capd Solutions and Capd Equipment & Accessories. Based on dialysis modality, the market is segmented into Traditional CAPD and Automated CAPD (APD). Based on patient type, the market is segmented into Adult Patients, Pediatric Patients and Geriatric Patients. Based on end users, the market is segmented into Hospitals, Dialysis Centers (Independent), Home Healthcare Settings, Specialty Clinics and Others. Based on distribution channel, the market is segmented into Online and Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market

The growing incidence of chronic kidney disease is significantly increasing the number of patients in need of dialysis, which in turn drives demand for convenient, home-based treatment options like continuous ambulatory peritoneal dialysis (CAPD). As healthcare systems move towards outpatient care, both clinicians and patients favor solutions that promote independence and lower reliance on medical facilities. This shift fosters investments in training, supplies, and supportive services to enhance the accessibility and acceptance of CAPD. Consequently, the market experiences expansion as more patients seek the convenience of home treatments, while providers focus on effective capacity management and improving continuity of care.

Restraints in the Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market

The Global Continuous Ambulatory Peritoneal Dialysis (CAPD) market faces significant challenges due to insufficient and fragmented reimbursement systems for home dialysis services and supplies. This lack of consistent coverage creates financial uncertainty for both patients and providers, leading to reluctance in opting for CAPD. Healthcare providers may be unwilling to invest resources into the necessary training and home support without assured payment pathways, while suppliers deal with unpredictable market access. Consequently, this situation hinders clinician recommendations and patient acceptance, limits investment in service networks, and impedes the development of essential infrastructure necessary for the broader adoption of CAPD in various healthcare environments.

Market Trends of the Global Continuous Ambulatory Peritoneal Dialysis (Capd) Market

The Global Continuous Ambulatory Peritoneal Dialysis (CAPD) market is witnessing a significant trend towards home-based care, driven by a growing preference among providers and patients for peritoneal dialysis modalities that facilitate treatment outside traditional healthcare settings. This shift is fueling investments in patient education and nursing support programs, along with efforts to simplify device designs for enhanced usability. Payers and health systems are prioritizing continuity of care, reduced hospital dependence, and improved patient quality of life, leading to increased collaborations aimed at optimizing training and supply logistics. Manufacturers are responding by enhancing the portability and convenience of consumables, thus promoting decentralized delivery models, bolstering caregiver engagement, and fostering integrated care pathways that align clinical outcomes with a patient-centered approach.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Capd Solutions
  • Standard Dextrose Solutions
  • Icodextrin Solutions
  • Amino Acid Solutions
• Capd Equipment & Accessories
  • Catheters
  • Transfer Sets
  • Connectors
  • Other Accessories

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Dialysis Modality & CAGR (2026-2033)

• Market Overview
• Traditional CAPD
• Automated CAPD (APD)

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Adult Patients
• Pediatric Patients
• Geriatric Patients

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Hospitals
• Dialysis Centers (Independent)
• Home Healthcare Settings
• Specialty Clinics
• Others

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Online
• Offline

Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size & CAGR (2026-2033)

• North America (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Dialysis Modality, Patient Type, End Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDX, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Health Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dialysis Clinic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gambro AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NxStage Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DaVita Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbot Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polymedicure Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renal Services Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations